News

The new experimental weight loss drug, Retatrutide, is showing promising results. According to a study in the Annals of ...
TUCSON, AZ / ACCESS Newswire / April 29, 2025 / Retatrutide, also known as LY3437943 ... contributing to weight loss and metabolic health improvements. This multi-receptor activation yields ...
which showed weight loss of around 19% at 46 weeks in a study reported earlier at the ADA, but had also not reached a plateau. Lilly is losing no time in advancing retatrutide into phase 3 testing ...